Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

AstraZeneca guides FTSE 100 higher; buyout powers Cobham

Published 25/07/2019, 17:25
Updated 25/07/2019, 17:25
© Reuters. Financial traders work at their desks at CMC Markets in the City of London

By Shashwat Awasthi and Muvija M

(Reuters) - London's FTSE 100 lost ground on Thursday with a slew of negative earnings readings from blue-chips including spirits company Diageo , while AstraZeneca was a stand-out performer after raising its 2019 product sales forecast.

The main stock market index (FTSE) inched lower by 0.2%, but still outperformed its U.S. and European counterparts, while the mid-cap FTSE 250 (FTMC) was up 0.2% with gains led by aerospace firm Cobham (LON:COB) that surged after a buyout offer.

Diageo (L:DGE) slumped 3.4% after its capital return plans were less than what some analysts had expected, though the company reported higher annual profit helped by the popularity of its "Game of Thrones" inspired scotch.

Software firm Sage (L:SGE) and information and analytics provider Relx (L:REL) slumped 10.4% and 3.7%, respectively, after downbeat updates, while consumer goods giant Unilever (L:ULVR) fell as rainy weather hit ice cream sales in Europe and North America.

Helping contain the losses was AstraZeneca (L:AZN), which jumped nearly 8% to an all-time high after raising its annual product sales forecast, as cancer drugs helped its second-quarter results beat analysts' estimates.

Market sentiment broadly weakened after the European Central Bank meeting, in which ECB President Mario Draghi all but pledged to ease policy further as the growth outlook deteriorates, and said that there was no discussion of a rate cut.

"Draghi indicated they didn't really even discuss a cut today so that's what surprised the market and that's why we're seeing this reversal, but it doesn’t change the bigger picture," said Jeremy Gatto, investment manager at Cross Assets Solutions team in Unigestion.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Among midcaps, Cobham soared 34.5% to 165.8 pence, roughly matching the 165 pence per share offered by U.S. private equity group Advent International that valued the London-listed company at $5 billion.

"It's the latest sign that more firms are happy to go private and take them out of the glare of public markets," Wilson said. "It's also a sign that weakness in sterling continues to make UK companies attractive to foreign buyers."

However, gains on the FTSE 250 were kept in check by Metro Bank (L:MTRO), which plunged more than 19% to an all-time low after it disclosed that customers had pulled 2 billion pounds out this year following an accounting error and said its founder would stand down as chairman.

Shares of Aston Martin (L:AML), which shed over a quarter of their value after the luxury carmaker cut its 2019 volumes forecast in the previous session, fell another 18%, deepening its losses for the year to 47%.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.